Search Results 451-460 of 18035 for progesterone

1. Skin Appearance and Quality of Life in Breast Cancer Survivors on Aromatase Inhibitor Therapy - Mayo Clinic

   Histologically confirmed adenocarcinoma of the breast stage 0-III with estrogen receptor (ER) and/or progesterone receptor (PR) positive per ASCO/CAP ...

2. Primary ovarian insufficiency - Symptoms and causes - Mayo Clinic

   This condition, also called premature ovarian failure, happens in women under age 40. Hormone therapy can lessen symptoms.

3. Assess Glycemic Improvements in People with Type 2 Diabetes Using a Novel Hybrid Closed Loop Insulin Pump - Mayo Clinic

   Combined estrogen and progesterone containing hormonal contraception associated with inhibition ofovulation (oral, intravaginal, transdermal). Progestogen ...

4. MC1733, Phase I Trial of Intratumoral Administration of a Measles Virus Derivative Expressing the Helicobacter pylori Neutrophil-activating Protein (NAP) (MV-s-NAP) in Patients with Metastatic Breast Cancer - Mayo Clinic

   * Pathologically confirmed invasive breast adenocarcinoma with documented estrogen receptor (ER)/progesterone receptor (PR)/human epidermal growth factor ...

5. A Study of MBG453 in Combination With Azacitidine and Venetoclax in AML Patients Unfit for Chemotherapy - Mayo Clinic

   Use of oral (estrogen and progesterone), injected or implanted combined hormonal methods of contraception or placement of an intrauterine device (IUD) or ...

6. Medical Research & Education - Mayo Clinic News Network

   JACKSONVILLE, Fla. — A new study led by Mayo Clinic found that postmenopausal women receiving menopausal hormone therapy lost 35% more weight while taking ...

7. Medical Research & Education - Mayo Clinic News Network

   JACKSONVILLE, Fla. — A new study led by Mayo Clinic found that postmenopausal women receiving menopausal hormone therapy lost 35% more weight while taking ...

8. T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer - Mayo Clinic

   ... progesterone receptor (PR) status; hormone receptor negative status must be determined by both known negative ER and known negative PR - Patients with ...

9. Deucravacitinib (BMS-986165) for Pityriasis Rubra Pilaris - Mayo Clinic

   Use of oral (estrogen and progesterone), injected or implanted hormonal methods of contraception or other forms of hormonal contraception that have ...

10. Medical Research & Education - Mayo Clinic News Network

    JACKSONVILLE, Fla. — A new study led by Mayo Clinic found that postmenopausal women receiving menopausal hormone therapy lost 35% more weight while taking ...